Since the nuclear receptor PPAR-γ is known to exert a variety of anti-inflammatory effects and unsaturated long-chain NFAs are activating ligands for PPAR-γ, we hypothesized that pulmonary delivery of an NFA would diminish the severity of ALI. The gene discussed is PPARG; the disease is acute respiratory distress syndrome.